VEGFA and neoplasm: Promising biomarker candidates include the concentration ranges of circulating angiogenic molecules (such as plasma levels of VEGF) [13,14], tissue markers (tumour microvessel density) [15–18] and imaging parameters (magnetic resonance imaging-measured Ktrans) [15,19,20].